{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T14:17:46Z","timestamp":1788617866674,"version":"build-2803163510"},"reference-count":29,"publisher":"Japan Endocrine Society","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Endocr J"],"published-print":{"date-parts":[[2023]]},"DOI":"10.1507\/endocrj.ej23-0050","type":"journal-article","created":{"date-parts":[[2023,4,12]],"date-time":"2023-04-12T22:10:34Z","timestamp":1681337434000},"page":"559-565","source":"Crossref","is-referenced-by-count":23,"title":["Paraneoplastic autoimmune hypophysitis: a novel form of paraneoplastic endocrine syndrome"],"prefix":"10.1507","volume":"70","author":[{"given":"Yutaka","family":"Takahashi","sequence":"first","affiliation":[{"name":"Department of Diabetes and Endocrinology, Nara Medical University, Kashihara 634-8522, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"386","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1 Onyema MC, Drakou EE, Dimitriadis GK (2022) Endocrine abnormality in paraneoplastic syndrome. Best Pract Res Clin Endocrinol Metab 36: 101621.","DOI":"10.1016\/j.beem.2022.101621"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2 Sardina Gonzalez C, Martinez Vivero C, Lopez Castro J (2022) Paraneoplastic syndromes review: the great forgotten ones. Crit Rev Oncol Hematol 174: 103676.","DOI":"10.1016\/j.critrevonc.2022.103676"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3 Dimitriadis GK, Angelousi A, Weickert MO, Randeva HS, Kaltsas G, et al. (2017) Paraneoplastic endocrine syndromes. Endocr Relat Cancer 24: R173\u2013R190.","DOI":"10.1530\/ERC-17-0036"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4 Kaltsas G, Androulakis II, de Herder WW, Grossman AB (2010) Paraneoplastic syndromes secondary to neuroendocrine tumours. Endocr Relat Cancer 17: R173\u2013R193.","DOI":"10.1677\/ERC-10-0024"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5 Nieman LK (2022) Molecular derangements and the diagnosis of ACTH-dependent Cushing\u2019s syndrome. Endocr Rev 43: 852\u2013877.","DOI":"10.1210\/endrev\/bnab046"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6 Zhang C, Jin J, Xie J, Ye L, Su T, et al. (2020) The clinical features and molecular mechanisms of ACTH-secreting pancreatic neuroendocrine tumors. J Clin Endocrinol Metab 105: dgaa507.","DOI":"10.1210\/clinem\/dgaa507"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7 Ye L, Li X, Kong X, Wang W, Bi Y, et al. (2005) Hypomethylation in the promoter region of POMC gene correlates with ectopic overexpression in thymic carcinoids. J Endocrinol 185: 337\u2013343.","DOI":"10.1677\/joe.1.05963"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8 Araki T, Tone Y, Yamamoto M, Kameda H, Ben-Shlomo A, et al. (2021) Two distinctive POMC promoters modify gene expression in Cushing disease. J Clin Endocrinol Metab 106: e3346\u2013e3363.","DOI":"10.1210\/clinem\/dgab387"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9 Kumari N, Dwarakanath BS, Das A, Bhatt AN (2016) Role of interleukin-6 in cancer progression and therapeutic resistance. Tumour Biol 37: 11553\u201311572.","DOI":"10.1007\/s13277-016-5098-7"},{"key":"10","doi-asserted-by":"publisher","unstructured":"10 Chesnokova V, Melmed S (2002) Minireview: neuro-immuno-endocrine modulation of the hypothalamic-pituitary-adrenal (HPA) axis by gp130 signaling molecules. Endocrinology 143: 1571\u20131574.","DOI":"10.1210\/en.143.5.1571"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11 Luongo C, Trivisano L, Alfano F, Salvatore D (2013) Type 3 deiodinase and consumptive hypothyroidism: a common mechanism for a rare disease. Front Endocrinol (Lausanne) 4: 115.","DOI":"10.3389\/fendo.2013.00115"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12 Weber Pasa M, Selbach Scheffel R, Borsatto Zanella A, Maia AL, Dora JM (2017) Consumptive hypothyroidism: case report of hepatic hemangioendotheliomas successfully treated with vincristine and systematic review of the syndrome. Eur Thyroid J 6: 321\u2013327.","DOI":"10.1159\/000481253"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13 Noland CL, Chua HC, Kschonsak M, Heusser SA, Braun N, et al. (2022) Structure-guided unlocking of Na(X) reveals a non-selective tetrodotoxin-sensitive cation channel. Nat Commun 13: 1416.","DOI":"10.1038\/s41467-022-28984-4"},{"key":"14","doi-asserted-by":"publisher","unstructured":"14 Hiyama TY, Matsuda S, Fujikawa A, Matsumoto M, Watanabe E, et al. (2010) Autoimmunity to the sodium-level sensor in the brain causes essential hypernatremia. Neuron 66: 508\u2013522.","DOI":"10.1016\/j.neuron.2010.04.017"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15 Nakamura-Utsunomiya A, Goda S, Hayakawa S, Sonoko S, Hoorn EJ, et al. (2022) Identification of clinical factors related to antibody-mediated immune response to the subfornical organ. Clin Endocrinol (Oxf) 97: 72\u201380.","DOI":"10.1111\/cen.14737"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16 Nakamura-Utsunomiya A (2022) Autoimmunity related to adipsic hypernatremia and ROHHAD syndrome. Int J Mol Sci 23: 6899.","DOI":"10.3390\/ijms23136899"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17 Bando H, Kanie K, Takahashi Y (2022) Paraneoplastic autoimmune hypophysitis: an emerging concept. Best Pract Res Clin Endocrinol Metab 36: 101601.","DOI":"10.1016\/j.beem.2021.101601"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18 Yamamoto M, Iguchi G, Takeno R, Okimura Y, Sano T, et al. (2011) Adult combined GH, prolactin, and TSH deficiency associated with circulating PIT-1 antibody in humans. J Clin Invest 121: 113\u2013119.","DOI":"10.1172\/JCI44073"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19 Kanie K, Bando H, Iguchi G, Muguruma K, Matsumoto R, et al. (2019) Pathogenesis of anti-PIT-1 antibody syndrome: PIT-1 presentation by HLA class I on anterior pituitary cells. J Endocr Soc 3: 1969\u20131978.","DOI":"10.1210\/js.2019-00243"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20 Yamamoto M, Iguchi G, Bando H, Kanie K, Hidaka-Takeno R, et al. (2020) Autoimmune pituitary disease: new concepts with clinical implications. Endocr Rev 41: bnz003.","DOI":"10.1210\/endrev\/bnz003"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21 Fujita Y, Bando H, Iguchi G, Iida K, Nishizawa H, et al. (2021) Clinical heterogeneity of acquired idiopathic isolated adrenocorticotropic hormone deficiency. Front Endocrinol (Lausanne) 12: 578802.","DOI":"10.3389\/fendo.2021.578802"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22 Patti G, Guzzeti C, Di Iorgi N, Maria Allegri AE, Napoli F, et al. (2018) Central adrenal insufficiency in children and adolescents. Best Pract Res Clin Endocrinol Metab 32: 425\u2013444.","DOI":"10.1016\/j.beem.2018.03.012"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23 Mizukoshi T, Fukuoka H, Takahashi Y (2022) Immune checkpoint inhibitor-related hypophysitis. Best Pract Res Clin Endocrinol Metab 36: 101668.","DOI":"10.1016\/j.beem.2022.101668"},{"key":"24","doi-asserted-by":"publisher","unstructured":"24 Bando H, Iguchi G, Kanie K, Nishizawa H, Matsumoto R, et al. (2018) Isolated adrenocorticotropic hormone deficiency as a form of paraneoplastic syndrome. Pituitary 21: 480\u2013489.","DOI":"10.1007\/s11102-018-0901-7"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25 Kanie K, Iguchi G, Bando H, Urai S, Shichi H, et al. (2021) Mechanistic insights into immune checkpoint inhibitor-related hypophysitis: a form of paraneoplastic syndrome. Cancer Immunol Immunother 70: 3669\u20133677.","DOI":"10.1007\/s00262-021-02955-y"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26 Hao L, Zhao X, Zhang B, Li C, Wang C (2015) Positive expression of pro-opiomelanocortin (POMC) is a novel independent poor prognostic marker in surgically resected non-small cell lung cancer. Tumour Biol 36: 1811\u20131817.","DOI":"10.1007\/s13277-014-2784-1"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27 Messager M, Carriere C, Bertagna X, de Keyzer Y (2006) RT-PCR analysis of corticotroph-associated genes expression in carcinoid tumours in the ectopic-ACTH syndrome. Eur J Endocrinol 154: 159\u2013166.","DOI":"10.1530\/eje.1.02077"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28 Takahashi Y (2022) Onco-immuno-endocrinology: an emerging concept that links tumor, autoimmunity, and endocrine disease. Best Pract Res Clin Endocrinol Metab 36: 101666.","DOI":"10.1016\/j.beem.2022.101666"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29 Takahashi Y (2022) The novel concept of \u201cOnco-Immuno-Endocrinology\u201d led to the discovery of new clinical entity \u201cparaneoplastic autoimmune hypophysitis\u201d. Best Pract Res Clin Endocrinol Metab 36: 101663.","DOI":"10.1016\/j.beem.2022.101663"}],"container-title":["Endocrine Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/endocrj\/70\/6\/70_EJ23-0050\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T04:42:27Z","timestamp":1688186547000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/endocrj\/70\/6\/70_EJ23-0050\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023]]},"references-count":29,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.1507\/endocrj.ej23-0050","relation":{},"ISSN":["0918-8959","1348-4540"],"issn-type":[{"value":"0918-8959","type":"print"},{"value":"1348-4540","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023]]},"article-number":"EJ23-0050"}}